Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Piromelatine (Neu-P11)
print preview
bookmark
share with colleague
General Information
Company
Neurim Pharmaceuticals Ltd.
Description
Melatonin MT1 and MT2 receptor agonist and serotonin (5-HT1A) and 5-HT1D receptor agonist
Molecular Target
Melatonin MT1 receptor
;
Serotonin (5-HT1A) receptor
Mechanism of Action
Melatonin MT1 receptor agonist
Latest Stage of Development
Phase II
Indication
Insomnia
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy